Financial Services

With two pivotal trial readouts looming and cash projected to last only into Q4, Tvardi Therapeutics faces a make-or-break year for its STAT3 inhibitors.

The legal finance giant appoints Travis Lenkner as COO and promotes Carrie Tendler, signaling a renewed focus on operational execution and asset recovery.

Travel tech giant Amadeus navigates geopolitical turbulence with solid Q1 growth, while a major acquisition signals a bold future for frictionless travel.

How one company turned its internal training program into a strategic powerhouse, earning a top award and creating a blueprint for the future of work.

As Baozun prepares its Q1 2026 report, investors watch to see if its brand management pivot can sustain momentum in a shifting Chinese e-commerce market.

Stroke recovery innovator Mobia Medical raised $150M in its IPO, but its stock stumbled on its first day, signaling a challenging road for its novel device.

The firm reported a 3.7% drop in net asset value and a net loss for Q1 2026, raising questions about its dividend sustainability despite a stable payout.

On Red Dress Day, Métis leaders passed a sacred trust to PM Carney, demanding an end to funding gaps and real action on the stalled MMIWG2S+ crisis.

The gas and convenience retailer's massive dividend hike follows a stellar quarter, showcasing financial strength in a shifting market.

Amidst a 20% workforce cut, Geospace Technologies reports wider losses, testing its high-stakes strategy to pivot from oil & gas to new tech markets.

Amid declining Q1 income and NAV, the lender bets on a major healthcare acquisition and a new buyback to bolster shareholder confidence and future growth.

As complex new global AI and data laws take effect, Canadian businesses are scrambling for guidance, fueling a boom in specialized advisory services.

Despite a Q1 net loss, Mach Natural Resources boosts its cash distribution and shifts capital to oil, signaling confidence in its operational strength.

Aptar Pharma and the FDA lead a critical mission to reinvent respiratory medicine, ensuring patient safety while tackling the climate impact of inhalers.

Semiconductor giant KLA announces a massive stock split and a 21% dividend hike, rewarding shareholders and making its stock more accessible to all.

Artivion posts strong Q1 results and acquires Endospan for its FDA-approved NEXUS system, yet lowers its full-year guidance. What's behind the mixed message?

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

The private energy giant posted $171M in free cash flow, cut debt, and earned a Fitch upgrade, signaling robust health amid market volatility.

Carrington acquires Valon Mortgage and adopts its AI platform, a landmark deal set to redefine the complex world of government mortgage servicing.

A strategic partnership between Southwire and SKILLED Nation injects another $100,000 into scholarships, tackling a critical national labor shortage.